Top compounds associated with response to CLEC5A


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CCLE pan-cancer AAC 0.13 0.006
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.13 0.006
mRNA Methotrexate FIMM pan-cancer AAC -0.38 0.007
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.007
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.13 0.007
mRNA AT7867 CTRPv2 pan-cancer AAC 0.091 0.007
mRNA Vandetanib FIMM pan-cancer AAC 0.5 0.008
mRNA A-770041 GDSC1000 pan-cancer AAC -0.13 0.008
mRNA AMG-706 FIMM pan-cancer AAC 0.46 0.008
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.008
Download CSV